Trilostane

Revision as of 19:56, 27 September 2011 by WikiBot (talk | contribs) (Protected "Trilostane": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Trilostane
File:Trilostane.svg
Clinical data
ATC code
Legal status
Legal status
  • Withdrawn (U.S.)
Pharmacokinetic data
Elimination half-life8 hours
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H27NO3
Molar mass329.433 g/mol

Trilostane is an inhibitor of 3 β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.[1] It was withdrawn from the United States market in April 1994.

Template:Pharma-stub

References

  1. ↑ Komanicky P, Spark RF, Melby JC. (1978). "Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis". Journal of Clinical Endocrinology and Metabolism. 47 (5): 1042–1051. PMID 233687. |access-date= requires |url= (help)

Template:Corticosteroids for systemic use

Retrieved from "https://www.wikidoc.org/index.php?title=Trilostane&oldid=607001"